Reviews and perspectives

David M. Stresser, Anna K. Kopec, Philip Hewitt, et al. Towards in vitro models for reducing or replacing the use of animals in drug testing. Nature Biomedical Engineering. 2023:1-6. doi:10.1038/s41551-023-01154-7

Amid Shakeri, Ying Wang, Yimu Zhao, et al. Engineering Organ-on-a-Chip Systems for Vascular Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(12):2241-2255. doi:10.1161/ATVBAHA.123.318233

LV Shiya, Enhui He, Jinping Luo, et al. Using Human-Induced Pluripotent Stem Cell Derived Neurons on Microelectrode Arrays to Model Neurological Disease: A Review. Advanced Science. 2023;10(33):2301828. doi:10.1002/advs.202301828

Anna Loewa, James J. Feng, Sarah Hedtrich. Human disease models in drug development. Nature Reviews Bioengineering. 2023;1(8):545-559. doi:10.1038/s44222-023-00063-3

Kimberly A. Homan. Industry Adoption of Organoids and Organs-on-Chip Technology: Toward a Paradox of Choice. Advanced Biology. 2023;7(6):2200334. doi:10.1002/adbi.202200334

Anubhab Mukherjee, Aprajita Sinha, Maheshree Maibam, et al. Organoids and Commercialization. In: Organoid Bioengineering - Advances, Applications and Challenges. IntechOpen; 2022. https://www.intechopen.com/chapters/81547.

Passley Hargrove-Grimes, Lucie A. Low, Danilo A. Tagle. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development. Cells Tissues Organs. 2022;211(3):269-281. doi:10.1159/000517422

María Virumbrales-Muñoz, Jose M. Ayuso. From microfluidics to microphysiological systems: Past, present, and future. Organs-on-a-Chip. 2022;4:100015. doi:10.1016/j.ooc.2022.100015

Nina S. Corsini, Juergen A. Knoblich. Human organoids: New strategies and methods for analyzing human development and disease. Cell. 2022;185(15):2756-2769. doi:10.1016/j.cell.2022.06.051

Jennifer E. Rood, Aidan Maartens, Anna Hupalowska, Sarah A. Teichmann, Aviv Regev. Impact of the Human Cell Atlas on medicine. Nature Medicine. 2022;28(12):2486-2496. doi:10.1038/s41591-022-02104-7